Recruiting
Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
NCT05212454
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- the Second Affiliated Hospital of Zhejiang Univercity School of Medicine Hanzhou, Zhejiang, China